lde225
Showing 1 - 21 of 21
Advanced Solid Tumor Cancers, Medulloblastoma, Basal Cell Carcinoma Trial in Hong Kong, Japan, Taiwan (LDE225)
Completed
- Advanced Solid Tumor Cancers
- +2 more
- LDE225
-
Hong Kong, Hong Kong
- +3 more
Dec 16, 2020
Normal Hepatic Function, Impaired Hepatic Function Trial in Worldwide (LDE225)
Completed
- Normal Hepatic Function
- Impaired Hepatic Function
- LDE225
-
Miami, Florida
- +4 more
Dec 16, 2020
Advanced Solid Tumor Cancers, Medulloblastoma, Basal Cell Carcinoma Trial in Worldwide (LDE225)
Completed
- Advanced Solid Tumor Cancers
- +2 more
- LDE225
-
Pittsburgh, Pennsylvania
- +4 more
Dec 16, 2020
Advanced Solid Tumor Trial in United States (LDE225, Wafarin, Bupropion)
Completed
- Advanced Solid Tumor
- LDE225
- +2 more
-
Duarte, California
- +12 more
Dec 16, 2020
Primary Myelofibrosis, Thrombocytosis, Essential Thrombocythemia Trial in Worldwide (LDE225, INC424)
Completed
- Primary Myelofibrosis
- +9 more
- LDE225
- INC424
-
Camperdown, New South Wales, Australia
- +17 more
Apr 3, 2020
Prostate Cancer Trial in Hackensack (Docetaxel, Prednisone, LDE225)
Withdrawn
- Prostate Cancer
- Docetaxel
- +2 more
-
Hackensack, New JerseyJohn Theurer Cancer @ HackensackUMC
Jun 17, 2019
Prostate Cancer Trial in Baltimore (LDE225)
Completed
- Prostate Cancer
- LDE225
-
Baltimore, MarylandJohns Hopkins Hospital
Nov 13, 2018
Hepatocellular Carcinoma, Cirrhosis Trial in La Jolla (LDE225)
Completed
- Hepatocellular Carcinoma
- Cirrhosis
- LDE225
-
La Jolla, CaliforniaUCSD Moores Cancer Center
Mar 3, 2019
GVHD Trial in Boston (LDE225)
Terminated
- Graft Versus Host Disease
- LDE225
-
Boston, Massachusetts
- +2 more
Mar 15, 2018
Basal Cell Carcinoma Trial in Stanford (LDE225)
Completed
- Basal Cell Carcinoma
- LDE225
-
Stanford, CaliforniaStanford University, School of Medicine
Nov 23, 2016
Pancreatic Ductal Adenocarcinoma Trial in Salt Lake City (LDE225)
Withdrawn
- Pancreatic Ductal Adenocarcinoma
- LDE225
-
Salt Lake City, UtahHuntsman Cancer Institute
Jun 7, 2016
PTCH1 or SMO Activated Solid and Hematologic Tumors Trial in United States (LDE225)
Terminated
- PTCH1 or SMO Activated Solid and Hematologic Tumors
- LDE225
-
Sacramento, California
- +9 more
Apr 25, 2016
Basal Cell Carcinoma, Gorlin Syndrome, Nevoid Basal Cell Carcinoma Syndrome Trial in Worldwide (LDE225, Placebo)
Completed
- Basal Cell Carcinoma
- +2 more
- LDE225
- Placebo
-
Wien, Austria
- +5 more
Sep 23, 2015